Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
99.7M
-
Shares change
-
+642K
-
Total reported value, excl. options
-
$948M
-
Value change
-
-$98.4M
-
Put/Call ratio
-
0.63
-
Number of buys
-
91
-
Number of sells
-
-82
-
Price
-
$9.51
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2022
237 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q1 2022.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.7M shares
of 157M outstanding shares and own 63.37% of the company stock.
Largest 10 shareholders include FMR LLC (20.3M shares), VANGUARD GROUP INC (12.1M shares), STATE STREET CORP (9.63M shares), BlackRock Inc. (8.94M shares), MAVERICK CAPITAL LTD (6.68M shares), WELLINGTON MANAGEMENT GROUP LLP (4.02M shares), 683 Capital Management, LLC (2.6M shares), GEODE CAPITAL MANAGEMENT, LLC (2.19M shares), MILLENNIUM MANAGEMENT LLC (2.18M shares), and GROUP ONE TRADING, L.P. (1.82M shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.